Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited will convene its 2025 Annual General Meeting on 29 May 2026 at 10:00 a.m. in the company’s conference room at 45 Sha Mian North Street, Liwan District, Guangzhou. On-site and online voting (for A-share investors) will be available. The meeting was approved at the 33rd meeting of the ninth Board of Directors.

Key resolutions to be tabled as ordinary items include: • Review of the 2025 annual report and Board report. • Deliberation on the 2025 profit distribution plan together with the 2026 interim cash-dividend arrangement. • Determination of 2026 remuneration for members of the ninth Board, prorated where applicable. • Approval of omnibus credit facilities for the company and its subsidiaries. • Re-appointment of WUYIGE Certified Public Accountants LLP as both external and internal-control auditor for 2026.

Cumulative-voting items focus on Board renewal: • Election of six non-independent directors and four independent directors to the tenth Board, with accompanying 2026 remuneration packages.

Shareholder logistics: • The H-share register will close from 23 May 2026 to 29 May 2026 (both days inclusive). Only H-shareholders recorded on 29 May 2026 may attend and vote. • H-share transfer documents must reach Computershare Hong Kong Investor Services Limited by 4:30 p.m. on 22 May 2026. • Proxy forms must be lodged no later than 24 hours before the meeting.

The AGM is expected to last half a day; attendees bear their own travel and accommodation costs.